Urologic Cancer clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Sorry, in progress, not accepting new patients
This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by surveillance for the treatment of participants with IR-NMIBC.
at UC Davis UC Irvine
Last updated: